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ABSTRACT
Medicinal plants, since times immemorial, have been used in virtually all cultures for therapeutic purposes. The widespread use
of herbal remedies and healthcare preparations obtained from commonly used traditional herbs and medicinal plants have been
traced to the occurrence of natural products with medicinal properties. In the present review, an attempt has been made to collect
the botanical, phytochemical, ethnomedicinal, pharmacological and toxicological information on Melia azedarach L. which is
used traditionally as an anthelmintic, diuretic, emmenagouge, expectorant, vermifuge, used in piles, used as astringent, used in
hysteria, leprosy, and in scrofula. Medicinally it has been shown to possess various pharmacological activities like antifungal,
anti-malarial, antibacterial, hepatoprotective, anti-oxidant, anti-fertility, anthelmintic, antipyretic and cytotoxic activities. The
available literature on the M. azedarach L. revealed that this plant contains many phytochemical constituents including alkaloids,
terpenoids, saponins, glycosides, phenolic compounds, flavonoids and rutins. The aim of this article is to review those medicinal
and pharmacological properties of M. azedarach which have been or still are being learned. The present review is therefore, an
effort to give a detailed survey of the literature on its traditional, phytochemical and pharmacological properties.
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INTRODUCTION
Melia azedarach L. (M. azedarach) is a small to medium size deciduous tree or shrub of 5-15 meter in height, a close relative of
Neem, from the Meliaceae family widely distributed in tropical and subtropical countries, contains phytochemical constituents
which makes it candidate in pest control. It has been shown to possess antimicrobial, insecticidal and nematicidal properties. It is
also known for its anti-fertility, anti-inflammatory, antipyretic, spermicidal and antiulcer activities 1.
Taxonomic Classification
Kingdom                                 Plantae
Order                                       Sapindales
Family                                     Maliaceae
Genus                                      Melia
Species Melia azedarach
Binomial name Melia azedarach Linn.
Vernacular names
Chinaberry, Persian lilac, pride of India, china tree, Indian lilac and breed tree (English; Bakain, Drek, Pejri, Padric (India);
Bakainu (Nepal); Thamga (Burma); Inia (Hawai); Alelaila (Peurto Rice); Jacino (Panama); Aleli (Venzulea); West Indian Lilak,
Lilac (West Indies); Lilas (Haiti, French); Cinnamumo (Brazili) and Zanzalacht(Jordan) 2.
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Distribution
M. azedarach is native to tropical Asia. It is widely distributed in Pakistan, India, Indonesia, Southeast Asia and Australia. It has
become naturalized in Philippines, United States of America, Brazil, Argentine and many African and Arab countries 2.
Botanical description
M. azedarach is a small to medium size deciduous tree or shrub of 5-15 meter in height. Branches are stout, with purplish bark
and dotted with buff-colored lenticels. Leaves are compound, alternate, and puberulent to glabrous. Leaves are long, serrate, dark
green above, often with sparse hair along the veins and lighter green and generally smooth below. Inflorescence is a panicle,
flowers are 5-parted. Sepals are green. Petals are pinkish lavender, lingulate with ten anthers. Fruit is drupe, one seeded, stalked
greenish yellow to yellowish tan, globose and 1-1.5 cm in diameter 3.
Phytochemistry
The M. azedarach contains a number of organic molecules i.e. flavonoids, terpenoids, steroids, acids and anthraquinones. A
variety of compounds have been detected in M. azedarach leaf extract including Kampherol, Quercetin (Flavonoids),
stigmasterol, Campesterol (phytosterols), β-sitosterol, Pyhtol (Diterpene), 3-Methyldecane, Heptadecane (alkane hydrocarbon),
hexadecanic acid, Pentadecanoic acid (n-alkanoic acids), β-Carotene, tocopherol (Vitamin-E) and saqulene, 1-Eicosanol (tri-
terpene), 3,5,11,15- Tetramethyl-2-hexadecen-1-ol (Terpene alcohol) 4.
Figure 1: Kampherol Figure 2: Quercetin
Figure 3: Liminoid
Chemical constituents of seeds including β-sitosterol, vanillin, benzoic acid, vanillic acid, daucosterol, β-D- glucopyranose,
liminoid glycoside viz 6,11-diacetoxy-7-oxo-14 beta-epoxymeliacin (1,5-diene-3-O-beta-D-glucopyranoside) and melianol
meliacin, meliacarpin, meliartenin vanillin, hydroxyl-3-methoxcinnamaldehyde and (±) pinoresinol 5. Stem bark contain
liminoids such as 7α- Acetoxy-14β, 15β-epoxygedunan-1-ene-3-O-β-D-glucopyranoside . Anthraquinone such as 1, 3, 5, 8-
Tetrahydroxy-2-methylanthraquinone; 8-Me ether, 3-O-α-L- rhamnopyranoside.
Root bark contains terpenoids such as Azedarachtin-A, Azedarachtin-B 1. The methanolic extract of the M. azedarach showed 48
constituents, the major constituents are Quercetin (16.47%- Flavanoids), Phytol (11.04%-Diterpene), Palmitic acid (15.49%-
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saturated fatty acid). 9,12,15- Octadecatrienoic acid (3.43%-n-alkanoic acids) work as an anti inflammatory, hypocholesterolemic
cancer preventive, nematicide, insecticide, hepatoprotective, antihistaminic properties 6. Some minor components like 2,3-
Dihydro-3,5-Dihydroxy-6-Methyl-4H-pyran-4-One (0.31%-flavoring agent) and 4-Methyl-2-hexanone (2.25%-flavoring agent)
consider as a novel potent aroma compound in a dairy product 7. The compound 2, 3- Dihydrobenzofuran (0.22%) is an essential
oil used in the treatment of diabetic retinopathy and arthritis 8. 5-hydroxypipecolic acid (0.52%-imino acid) showed platelet
aggregation inhibition and larvicidal activity Limonene (0.68%) acts as natural food flavorings, used in fragrances and
aromatherapy 9. Pyrazol-5(2H)-one (0.26%- flavonoids) possessed extensive biological activities, such as anti inflammatory,
antipyretic, analgesic 10.
ETHANOBOTANICAL USES
The exuded gum obtained from M. azedarach trunk is considered useful in spleen enlargement, wood extract given in asthma 11.
Decoction of bark is prescribed in paroxysmal fever to relive thirst, nausea, vomiting and general debility, and loss of appetite
and skin diseases 11.
Poultice of the leaves are applied to relieve nerve headache and to cure eruption on the scalp. Leaf juice is act as anthelmintic,
diuretic, emmenagouge, expectorant, vermifuge and their decoction is astringent, stomachic, used in hysteria, leprosy, scrofula
11,12
. Flowers have astringent, anodyne, refrigerant, emmenagouge, diuretic, resolvent, deobsturent properties 13.
Fruits are considered anthelmintic, diuretic, emollient and purgative also, prescribed internally in indigestion, colic and intestinal
catarrah 14.
Seeds are considered anthelmintic, expectorant, aphrodisiac and are useful in typhoid fever, helminthiasis, pain in the pelvic
region and scrofula, also prescribed in rheumatism. Seed oil is used in skin diseases. Roots are astringent, emmenagouge,
anodyne, febrifuge, expectorant, constipating. These are useful in sciatica, lumbago, piles, cough, asthma, ulcers, wounds,
diabetes, intermittent fever, post labor pain in uterus, amenorrhea and in leuoderma 13.
PHARMACOLOGICAL ACTIVITIES
Hepatoprotective activity
The liver can be injured by various chemicals and drugs. In the study conducting by Ahmed et al in the year 2012, revealed the
hepatoprotective activity against CCl4 induced liver injury. Parameters like SGOT, SGPT, ALP and serum bilirubin were
measured and histopathological evaluation was conducted. Biochemical parameters have improved after treatment and
histological changes such as steatosis (fatty changes in hepatocytes) and fibrosis which were observed in CCl4 intoxicated group
were totally reduced to normal levels. Further investigations are in progress to determine the exact phytoconstituents responsible
for hepataprotective effect 15.
Anti-fertility activity
Rapid increase in population has caused severe problem in economic growth and human progression. Several methods of
contraception have been promoted, but due to their serious adverse effects, such as hormonal imbalance, hypertension, and
increased risk of cancer and weight gain, therefore, search for new antifertility molecule with minimum side effects continues.
Vishnukanta and Rana in the year 2009 studied hydro-alcoholic extract of M. azedarach roots for anti-implantation,
estrogenic/anti-estrogenic and progestational/anti-progestational activities. It was found that the extract exhibited significant anti-
implantation and anti-progestational activity and devoid of estrogenic/anti-estrogenic activity. It is therefore assumed that a
certain substance was present in the extract which impairs the synthesis, secretion and functions of ovarian steroids and also
blocks the implantation process by hindering the development of oocycte and graffian follicle as well as the endometrial
epithelium 16.
Folliculogenesis inhibition
Roop et al in 2005 conducted a study to investigate the quantitative aspects of follicular development in cyclic female albino rats
(135 ± 10 g; 8 groups with 6 animals in each group) after oral administration of polar (PF) and non-polar (NPF) fractions of M.
azedarach Linn. (dharek) seed extract at 24 mg kg body weight-1 day-1 for 18 days. There was a significant reduction (p< 0.05)
in the number of normal single layered follicles (M. azedarach: 0.60 ± 0.40 and 1.80 ± 1.2 after 24 mg/kg PF and NPF,
respectively, vs control: 73.40 ± 7.02) and follicles in various stages (I-VII) of follicular development in all treatment groups.
These extracts also significantly reduced (p<0.05) the total number of normal follicles in dharek (13.00 ± 3.58 and 14.60 ± 2.25
after 24 mg/kg NPF and PF) treatments compared to control (216.00 ± 15.72 and 222.20 ± 19.52, respectively). Thus, the present
study is an attempt to investigate the effects of M. azedarach seed extracts on reproduction of albino rats 17.
Antioxidant activity
A study was designed by Munir et al in the year 2012 to demonstrate the antioxidant activity of M. azedarach. The TPC (Total
Phenolic Contents) and TFC (Total Flavonoid Contents) contents in different parts of sun dried extracts of M. azedarach were
found to be in the range of 74.43-112.10 mg GAE/g DW and 13.32-28.11 mg CE/g DW, while in ambient dried TPC (Total
Phenolic Contents) and TFC (Total Flavonoid Contents) found to be in the range of 66.89-103.34 mg GAE/g DW and 10.67-
23.45 mg CE/g DW, respectively. The DPPH scavenging activity and linoleic inhibition capability of sun dried was found to be
in the range of 55.43-63.86% and 35.57-52.11%, respectively while for ambient dried was in the range of 48.54-61.00% and
33.87-50.33%, correspondingly. The reducing potential of sun dried and ambient dried at concentration of 10.0 mg/mL was in the
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range of 0.727-1.211 and 0.601-0.890, respectively. The result of the study, therefore, showed the sun dried extracts of M.
azedarach had higher antioxidant activity whereas, among the plant parts, the stem bark was found to be proved better
antioxidant activity 18. Ahmed et al in 2012 conducted a research study and concluded that phenols are responsible for the
variation in the antioxidant activity of the plant. The high DPPH scavenging activity of M. azedarach may be due to hydroxyl
groups present in the phenolic compounds. They possess antioxidant effect by inactivating lipid free radicals or preventing
decomposition of hydroperoxides into free radicals. One of the major plant compounds with antioxidant activity is polyphenols.
The -OH groups in phenolic compounds are considered have a significant role in antioxidant activity. It is reported, the
antioxidant activity of phenolic compounds is be mainly due to their redox properties 19.
Antipyretic activity
Recently in 2013, we conducted a trial in which hydro-methanolic extract of M. azedarach leaves exhibited significant
(p<0.0001) antipyretic effects at 500 mg/kg dose. The extract showed significant (p<0.0001) reduction in yeast-induced elevated
temperature as compared with that of standard drug paracetamol whereas the extract dose 250 mg/kg was less effective when
compared with higher dose (p<0.05) against baker yeast induced pyrexia method in experimental animals. Antipyretic activity of
M. azedarach might be due to the flavonoids and or the alkaloidal components of the plants extracts 20.
Cytotoxicity activity
Jafari et al in the year 2013 conducted a study to evaluate the anticancer activity of M. azedarach in comparison with A. indica on
cancer cell lines and also to evaluate their safety in humans by testing them on normal cell line. The study also aimed to
determine the active chemical constituents that are responsible for therapeutic effects of M. azedarach in traditional usages. In
this study, the cytotoxic activity of crude extracts from M. azedarach and A. indica leaves, pulps and seeds as well as three main
fractions of their leaf extracts were determined against HT-29, A-549, MCF-7 and HepG-2 and MDBK cell lines. MTT assay was
used to find their cytotoxic activities. Methanol leaf fraction of M. azedarach was subjected for phytochemical study. Results of
the present study showed that seed kernel extract of M. azedarach exhibited the highest cytotoxic activity and selectivity to
cancer cell lines (IC50 range of 8.18- 60.10 µg mL-1). A. indica, crude pulp and crude leaf extracts of this plant showed
remarkably stronger anti-prolifrative activity (IC50 ranges of 83.45-212.16µg/mL-1 and 34.11-95.51 µg/mL-1 respectively) than
those of M. azedarach (all IC50 values of both plants >650 µg/mL-1). Four flavonol 3-O-glycosides including rutin, kaempferol-
3-O-robinobioside, kaempferol-3-O-rutinoside and isoquercetin along with a purin nucleoside, β-adenosine were isolated in
phytochemical analysis. Methanol leaf fraction of M. azedarach seems to be safer in terms of cytotoxicity. Flavonols are
abundant in the leaves of M. azedarach and these compounds seem to be responsible for many of medicinal effects exploited in
the traditional uses 21.
Effect of M. azedarach against bacterial infections
The flower extract of M. azedarach was prepared and used to treat bacterial skin infection in children by Saleem and his
collegues in 2002 22. Cream was prepared by methanol flower extract of M. azedarach. Neomycin was used as a standard drug.
The result showed that cream possesses significant cure in several cases. In another study by Saleem et al in 2008 in which
extract of M. azedarach flower showed potential in curing rabbits suffering from skin infection produced by Staphlococcus
aureus 23. The effect was compare with standard drug neomycin.
Antiviral activity
A peptide “Meliacine” isolated from M. azedarach leaves was found to inhibit the multiplication of foot and mouth disease
viruses reported in a previous study by Wachsman in 1998 24.
Alche and his colleagues in 2001 reported that another compound “Meliacarpin” found in the purified extract of M. azedarach
leaves inhibits the Vasicular stomatitis and Herpes simplex virus multiplication in vitro when added after infection with no
cytotoxic effects 25.
Antibacterial activity
Rhaymah in the year 2006 studied the antibacterial activity of the crude leaf extract of (methanol, ethanol, dichloromethane, ethyl
acetate and aqueous) of M. azedarach against Gram negative and Gram positive bacterial strains using disk diffusion method.
Significant inhibition showed ethyl acetate and aqueous extracts of M. azedarach against bacteria tested 26.
Another study was conducted by Khan et al in 2011 on antibacterial potential of the polar and non-polar extracts of the seeds of
M. azedarach against eighteen hospital isolated human pathogenic bacterial strains. Petrol, benzene, ethyl acetate, methanol, and
aqueous extracts at five different concentrations (1, 2, 5, 10 and 15 mg/ml) were evaluated using disk diffusion method. All
extracts of the seeds showed significant antibacterial activity against tested pathogens. However, ethyl acetate extract revealed
the highest inhibition comparatively among all other extracts. Therefore, this study also favored the traditional uses of M.
azedarach reported earlier27.
Anti-nephrolithiasis
In vivo study was conducted by Christina et al in 2006 on rats to determine the effect of aqueous extract of M. azedarach on
ethylene glycol-induced nephrolithiasis 28. The result of the study showed that M. azedarach extract reduced the urinary calcium,
oxalate and phosphate levels. Thus M. azedarach possesses inhibitory potential on induced nephrolithiasis judged by serum and
urine levels of creatinine.
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Suppersion of inducible nitric oxide synthase (iNOS)
Lee et al in the year 2004 reported that two B- carboline alkaloids isolated from M. azedarach, 4, 8-dimethoxy-1-vinyl-B-
carboline and 4-methoxy-1-vinyl- B-carboline inhibits inducible nitric oxide synthase in lipopolysaccharide/interferon-γ-
activated RAW 264.7 cells through the inhibition of (iNOS) protein expression due to decreased mRNA transcription.




Antimalarial effect of methanol extract of fruit, bark and leaves of M. azedarach was studied by Charturvedi in 2006 on mice
against the malaria parasite Plasmodium berghei. The study showed that fruit and bark extracts have significant suppression
effect on parasitaemia. It was concluded M. azedarach has significant anti-malarial effect but less significant than chloroquine 30.
Antiulcer activity
Some active constituents present in the lipid fraction of M. azedarach extracts were experimented on rats under Gipsing-restrain
stress to induce ulcers by Moursi in 1994. The result demonstrated that lipid component of M. azedarach which is mainly
phytosterol fraction was capable to reduce the free and total HCl combined with reduction of total acidity, and significant
increases the volume of gastric juice thus showing its antiulcer potential 31.
Antiprotozoal activity
Lee and his fellows in the year 2007 reported that M. azedarach extract possesses the antiprotozoal effect on Trichomonas
vaginalis cells through the inhibition of cell multiplication as well as the impairment of protein synthesis 32.
Anthelmintic activity
The ethanol extract of M. azedarach was tested for its anthelmintic activity against the Tapworm Taenia solium and the
earthworm Pheretima postthuma using Piperazine phosphate as the standard drug in a study by Szewezuk et al in 2003. It was
showed by the result that the extract was found active against both the tapworm and the earthworm, also the result was better
against Tapworm than Piperazine phosphate 33.
Anti-complementary activity
The aqueous fruit extracts of M. azedarach and Cotoneaster prostratae were examined on rat complement by Kayastha in 1985.
Both extract showed significant anti-complementary activities on rat serum but total inhibition was achieved at higher M.
azedarach extract concentrations when compared with those of Cotoneaster prostratae 34.
Wound healing activity
Wound healing potential of M. azedarach leaves in alloxan induced diabetic rats was evaluated in 2011 by Vidya. Result showed
that the topical application of methanol leaf extract of M. azedarach possesses significant wound healing activity in alloxan
induced diabetic rats. Delay in wound healing process in diabetes mellitus believed to be largely caused by some basic
mechanisms, such as increased blood sugar that impairs blood flow and the release of oxygen, impaired local immune and cell
defenses and microbial infections. In this study it has been shown that the topical application of M. azedarach leaf extract
encourages wound healing in diabetic rats and its effect was analogous with standard povidone iodine. M. azedarach leaf extract
enhanced the wound healing in diabetic rats which may be due to its antimicrobial activity 35.
Toxicological evaluation
Toxicological study of M. azedarach flowers and berries was carried out by Rahman et al in 1991 on laboratory animals, i.e. rats
and mice by oral and intravenous routes. Aqueous and alcoholic extracts were found to be non-toxic at a dose of 1500 mg/kg
orally in mice and rats. LD50 was 395, 500mg/kg (flowers) and 700, 925mg/kg (berries) respectively when injected aqueous
extract intravenously, in mice and rats. Alcoholic and aqueous extracts of M. azedarach also showed a mild CNS sedative effect.
It was found in this study that the flowers and berries of M. azedarach are toxic to lower laboratory animals, i.e. rats and mice.
Toxicity depends on dose and on route of administration. Higher dose quantity of the extracts depresses markedly the respiratory
centre by both routes, oral as well as parenteral. This may be due to the direct action on the respiratory centers because in doses
where mortality was observed it was noted that death occurs due to the respiratory cessation. In doses of extracts where animal
survived beside respiratory depression, analgesic activity was also observed without the loss of consciousness 36.
CONCLUSION
Research in medicinal plants based remedies has gained a renewed focus recently. The reason is that other system of medicine
although effective but possesses number of side effects that often lead to hazardous effects. M. azedarach though known for its
pesticide value also possesses significant medicinal properties. Most of the work carried out on the various extracts of the
different parts of the plant. Chemical studies on M. azedarach revealed that typical constituents of this plant are alkaloids,
terpenoids, anthraquinones and flavonoids. Among them, some exhibit strong bioactivities, especially antifungal, antiviral, anti-
implantation and antimicrobial activities. Though M. azedarach has various medicinal applications, but it is need of hour to
explore its medicinal values at molecular level with the help of various techniques. Further studies should be conducted on M.
azedarach to evaluate the molecular mechanism of interaction of various plant based drugs with human body in different
diseases.
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